title: Implication of fibrate therapy for homocysteine.
authors.forename: I J
authors.initials: IJ
authors.lastname: Jonkers
authors.forename: F H
authors.initials: FH
authors.lastname: de Man
authors.forename: W
authors.initials: W
authors.lastname: Onkenhout
authors.forename: A
authors.initials: A
authors.lastname: van der Laarse
authors.forename: A H
authors.initials: AH
authors.lastname: Smelt
mesh_terms: D001629:Bezafibrate / Q000627:therapeutic use*; D003404:Creatinine / Q000097:blood / Q000652:urine; D018592:Cross-Over Studies; D004311:Double-Blind Method; D005260:Female; D006710:Homocysteine / Q000097:blood*; D006801:Humans; D015228:Hypertriglyceridemia / Q000188:drug therapy*; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D008055:Lipids / Q000097:blood*; D008297:Male
chemical_list: D000960:Hypolipidemic Agents; D008055:Lipids; D006710:Homocysteine; D003404:Creatinine; D001629:Bezafibrate